AVITA Medical
Builds RECELL-based wound-care products for burns, trauma, and skin defects.
$10.35
After-hours close+0.04 (+0.39%)
At close$10.31(−0.10%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 186.30%Insiders 3.29%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 24.84M · Float 23.89M · 96.2% free float
Institutions13F, as of Mar 31, 2026
80 holders · 46.28M shares · 27 new positions · 56 increased · 10 reduced · 15 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Orbimed Advisors LLC | 41.04M | 165.22% | +41.04Mnew | May 15, 2026 |
| Vanguard Capital Management LLC | 1.34M | 5.37% | +1.34Mnew | May 15, 2026 |
| BlackRock, Inc. | 1.13M | 4.56% | +53.4K | May 13, 2026 |
| Geode Capital Management, LLC | 543.0K | 2.19% | +63.8K | May 15, 2026 |
| State Street Corp | 429.0K | 1.73% | +10.7K | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 193.4K | 0.78% | +193.4Knew | May 8, 2026 |
| Northern Trust Corp | 183.2K | 0.74% | +19.8K | May 14, 2026 |
| Morgan Stanley | 157.6K | 0.63% | +7.9K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| David D. O'Toole | officer: CFO | 152.9K | 0.62% | Aug 24, 2026 |
| Robert McNamara | director | 109.0K | 0.44% | Jun 4, 2026 |
| Joseph Fralin Woody | director | 108.0K | 0.43% | Jun 10, 2026 |
| Nicole Kelsey | officer: Chief Legal Officer | 98.4K | 0.40% | Feb 19, 2026 |
| Jan Stern Reed | director | 73.2K | 0.29% | Jun 4, 2026 |
| Suzanne Crowe | director | 69.1K | 0.28% | Jun 4, 2026 |
| Jeremy Curnock Cook | director | 62.1K | 0.25% | Jun 4, 2026 |
| Lou Panaccio | director | 56.4K | 0.23% | Jun 5, 2025 |
| Michael E. Tarnoff | director | 48.5K | 0.20% | Jun 4, 2026 |
| Cary Guy Vance | director, officer: President and CEO | 40.8K | 0.16% | Jun 1, 2026 |
12 people have not refiled in the last 18 months (437.4K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 12, 2026 | David D. O'Tooleofficer: CFO | Purchase | 2,000 | $3.97 | 152,927 |
| Jun 9, 2026 | Joseph Fralin Woodydirector | Purchase · 3 lots | 15,200 | $4.13 | 107,961 |
| Jun 3, 2026 | Joseph Fralin Woodydirector | Purchase · 2 lots | 10,000 | $4.09 | 92,761 |
| May 20, 2026 | David D. O'Tooleofficer: CFO | Purchase | 2,000 | $4.26 | 145,927 |
| May 19, 2026 | David D. O'Tooleofficer: CFO | Purchase | 2,000 | $4.24 | 143,927 |
| Mar 11, 2026 | David D. O'Tooleofficer: CFO | Purchase | 1,800 | $4.78 | 141,927 |
| Feb 19, 2026 | David D. O'Tooleofficer: CFO | Purchase | 3,000 | $4.15 | 140,127 |
| Aug 28, 2025 | Robert McNamaradirector | Purchase | 10,000 | $4.50 | 86,771 |
CongressHouse and Senate disclosures
Not reported.